STO · SIMRIS-B.ST
Simris Alg AB (publ)
SEK 0.12-SEK 0.00 (-2.4%)
Simris Alg AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 37.44% below the high.
Loading market information…
STO · ORTI-B.ST · SEK
Stock price, earnings
Quote as of Oct 30, 2026, 08:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SEK. Historical prices are not a forecast.
Ortivus AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 45.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ortivus AB (publ)’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMed FleetCtrl, a a software application that regular controls, checklists, and documentation tailored for seamless fleet management; MobiMed Life, a heart safe solution. It also provides ambulance services, primary care, and rescue services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden. Ortivus AB (publ) is a subsidiary of Ponderus Invest AB.
Latest available per-share figures in SEK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 0.12-SEK 0.00 (-2.4%)
Simris Alg AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 37.44% below the high.
SEK 15.95-SEK 0.75 (-4.49%)
Scandinavian Real Heart AB (Publ)’s quoted price sits in the lower half of its reported 52-week range, 32.7% below the high.
SEK 3.11-SEK 0.08 (-2.51%)
AcouSort AB’s quoted price sits in the lower half of its reported 52-week range, 39.73% below the high.
SEK 1.60+SEK 0.02 (+1.27%)
Newbury Pharmaceuticals AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 79.7% below the high.
SEK 3.06-SEK 0.13 (-4.08%)
OncoZenge AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 70.23% below the high.
SEK 0.20SEK 0.00 (0.0%)
Aino Health AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 20.0% below the high.
SEK 0.56SEK 0.00 (0.0%)
ScandiDos AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 57.58% below the high.
SEK 0.18-SEK 0.00 (-1.1%)
Modus Therapeutics Holding AB’s quoted price sits in the lower half of its reported 52-week range, 69.8% below the high.
